{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-056064","form_type":"8-K","ticker":"SEM","cik":"0001320414","company_name":"SELECT MEDICAL HOLDINGS CORP","filed_at":"2023-05-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:38.370175+00:00","generated_at":"2026-06-15T21:01:12.689838+00:00","sec_items":["2.02","8.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Select Medical Q1 revenue up 4.1% to $1.665B; net income up 52.4%; declares $0.125 dividend","bullets":["Revenue $1,665M (+4.1% YoY); net income $85.3M (+52.4%); EPS $0.56 (+51.3%).","Adjusted EBITDA $214.1M (+30.6%); operating income $151.5M (+45.7%).","Critical illness recovery hospital segment Adjusted EBITDA surged 113.5% to $76.8M; other segments also grew.","Declared $0.125/share dividend payable May 31 to holders of record May 18.","FY 2023 outlook: revenue $6.5B-$6.7B; Adjusted EBITDA $780M-$820M; EPS $1.75-$1.99."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-056064","json":"https://secwatch.observer/filing/0001104659-23-056064.json","markdown":"https://secwatch.observer/filing/0001104659-23-056064.md","text":"https://secwatch.observer/filing/0001104659-23-056064.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1320414/000110465923056064/0001104659-23-056064-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1320414/000110465923056064/tm2314609d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-15T21:01:12.689838+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"d07e749fca910436bb276bf68149edf711f3f945","claim":"SELECT MEDICAL HOLDINGS CORP reported first quarter ended March 31, 2023 results: revenue $1,665.0 million, net income $85.3 million, EPS $0.56.","evidence_excerpt":"For the first quarter ended March 31, 2023, revenue increased 4.1% to $1,665.0 million, compared to $1,599.5 million for the same quarter, prior year. Income from operations increased 45.7% to $151.5 million for the first quarter ended March 31, 2023, compared to $104.0 million for the same quarter, prior year. Net income increased 52.4% to $85.3 million for the first quarter ended March 31, 2023, compared to $55.9 million for the same quarter, prior year. Adjusted EBITDA increased 30.6% to $214.1 million for the first quarter ended March 31, 2023, compared to $163.8 million for the same quarter, prior year. Earnings per common share increased 51.3% to $0.56 for the first quarter ended March 31, 2023, compared to $0.37 for the same quarter, prior year.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1320414/000110465923056064/0001104659-23-056064-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"first quarter ended March 31, 2023"},{"label":"Revenue","value":"$1,665.0 million"},{"label":"Net income","value":"$85.3 million"},{"label":"EPS","value":"$0.56"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}